Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tolmar Australia Pty. Ltd.

Division of Mundipharma International Corp. Ltd.
www.tolmar.com.au

Latest From Tolmar Australia Pty. Ltd.

Deal Watch: Fresenius Buyout Of Akorn Potentially Threatened By Data Integrity Issues

AstraZeneca takes second license of antisense candidate under 2012 pact with Ionis, this time for kidney disease. Aldeyra is working with J&J on novel immune-modulating drugs for systemic inflammatory conditions.
Deals Business Strategies
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Australia
  • Parent & Subsidiaries
  • Mundipharma International Corp. Ltd.
  • Senior Management
  • Paul Vilner, General Mgr.
    Caroline Pilot, Head, Mktg.
    John Holbrow, Mgr., Fin. & Oper.
  • Contact Info
  • Tolmar Australia Pty. Ltd.
    Level 2/20 Bridge St.
    Pymble, 2073
    Australia
Advertisement
Advertisement
UsernamePublicRestriction

Register